DRI HEALTHCARE TRUST (DHT-UN.CA) Stock Fundamental Analysis

TSX:DHT-UN • CA23344H1091

15.84 CAD
0 (0%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis News
Fundamental Rating

4

DHT-UN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Pharmaceuticals industry. DHT-UN may be in some trouble as it scores bad on both profitability and health. A decent growth rate in combination with a cheap valuation! Better keep an eye on DHT-UN.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • DHT-UN had positive earnings in the past year.
  • In the past year DHT-UN had a positive cash flow from operations.
DHT-UN.CA Yearly Net Income VS EBIT VS OCF VS FCFDHT-UN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

  • DHT-UN has a Return On Assets (-5.75%) which is in line with its industry peers.
  • The Return On Equity of DHT-UN (-11.95%) is better than 60.61% of its industry peers.
  • DHT-UN's Return On Invested Capital of 4.55% is fine compared to the rest of the industry. DHT-UN outperforms 72.73% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DHT-UN is significantly below the industry average of 8.74%.
  • The 3 year average ROIC (1.94%) for DHT-UN is below the current ROIC(4.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -5.75%
ROE -11.95%
ROIC 4.55%
ROA(3y)4.16%
ROA(5y)N/A
ROE(3y)6.27%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
DHT-UN.CA Yearly ROA, ROE, ROICDHT-UN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • DHT-UN has a Operating Margin of 27.25%. This is amongst the best in the industry. DHT-UN outperforms 96.97% of its industry peers.
  • DHT-UN's Operating Margin has declined in the last couple of years.
  • The Profit Margin and Gross Margin are not available for DHT-UN so they could not be analyzed.
Industry RankSector Rank
OM 27.25%
PM (TTM) N/A
GM N/A
OM growth 3Y-6.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DHT-UN.CA Yearly Profit, Operating, Gross MarginsDHT-UN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • DHT-UN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for DHT-UN remains at a similar level compared to 1 year ago.
  • DHT-UN has a worse debt/assets ratio than last year.
DHT-UN.CA Yearly Shares OutstandingDHT-UN.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
DHT-UN.CA Yearly Total Debt VS Total AssetsDHT-UN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • DHT-UN has an Altman-Z score of 1.37. This is a bad value and indicates that DHT-UN is not financially healthy and even has some risk of bankruptcy.
  • DHT-UN's Altman-Z score of 1.37 is fine compared to the rest of the industry. DHT-UN outperforms 75.76% of its industry peers.
  • DHT-UN has a debt to FCF ratio of 4.45. This is a neutral value as DHT-UN would need 4.45 years to pay back of all of its debts.
  • DHT-UN has a Debt to FCF ratio of 4.45. This is in the better half of the industry: DHT-UN outperforms 78.79% of its industry peers.
  • DHT-UN has a Debt/Equity ratio of 0.90. This is a neutral value indicating DHT-UN is somewhat dependend on debt financing.
  • DHT-UN has a Debt to Equity ratio of 0.90. This is in the lower half of the industry: DHT-UN underperforms 69.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 4.45
Altman-Z 1.37
ROIC/WACC0.55
WACC8.27%
DHT-UN.CA Yearly LT Debt VS Equity VS FCFDHT-UN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • DHT-UN has a Current Ratio of 1.14. This is a normal value and indicates that DHT-UN is financially healthy and should not expect problems in meeting its short term obligations.
  • DHT-UN's Current ratio of 1.14 is on the low side compared to the rest of the industry. DHT-UN is outperformed by 75.76% of its industry peers.
  • DHT-UN has a Quick Ratio of 1.14. This is a normal value and indicates that DHT-UN is financially healthy and should not expect problems in meeting its short term obligations.
  • DHT-UN has a Quick ratio (1.14) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
DHT-UN.CA Yearly Current Assets VS Current LiabilitesDHT-UN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • DHT-UN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.41%.
  • DHT-UN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.09% yearly.
  • Looking at the last year, DHT-UN shows a quite strong growth in Revenue. The Revenue has grown by 16.24% in the last year.
  • The Revenue has been growing by 32.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-7.41%
EPS 3Y5.09%
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y32.25%
Revenue growth 5YN/A
Sales Q2Q%7%

3.2 Future

  • Based on estimates for the next years, DHT-UN will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.93% on average per year.
  • The Revenue is expected to grow by 14.54% on average over the next years. This is quite good.
EPS Next Y-4.68%
EPS Next 2Y2.83%
EPS Next 3Y9.29%
EPS Next 5Y16.93%
Revenue Next Year11.36%
Revenue Next 2Y6.43%
Revenue Next 3Y6.13%
Revenue Next 5Y14.54%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DHT-UN.CA Yearly Revenue VS EstimatesDHT-UN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
DHT-UN.CA Yearly EPS VS EstimatesDHT-UN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.04 indicates a rather cheap valuation of DHT-UN.
  • Compared to the rest of the industry, the Price/Earnings ratio of DHT-UN indicates a rather cheap valuation: DHT-UN is cheaper than 90.91% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, DHT-UN is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 6.90, the valuation of DHT-UN can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, DHT-UN is valued cheaply inside the industry as 87.88% of the companies are valued more expensively.
  • DHT-UN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.69.
Industry RankSector Rank
PE 7.04
Fwd PE 6.9
DHT-UN.CA Price Earnings VS Forward Price EarningsDHT-UN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DHT-UN is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DHT-UN indicates a rather cheap valuation: DHT-UN is cheaper than 81.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.62
EV/EBITDA 8.34
DHT-UN.CA Per share dataDHT-UN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.83%
EPS Next 3Y9.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • DHT-UN has a Yearly Dividend Yield of 4.57%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.25, DHT-UN pays a better dividend. On top of this DHT-UN pays more dividend than 100.00% of the companies listed in the same industry.
  • DHT-UN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 4.57%

5.2 History

  • DHT-UN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DHT-UN.CA Yearly Dividends per shareDHT-UN.CA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y2.83%
EPS Next 3Y9.29%
DHT-UN.CA Yearly Income VS Free CF VS DividendDHT-UN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 50M 100M 150M

More info and screens

Find the best dividend stocksShow peers with best dividend

DRI HEALTHCARE TRUST

TSX:DHT-UN (2/12/2026, 7:00:00 PM)

15.84

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-05
Earnings (Next)03-02
Inst Owners51.16%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner ChangeN/A
Market Cap872.94M
Revenue(TTM)192.69M
Net Income(TTM)-52.23M
Analysts80
Price Target22.04 (39.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.57%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.74%
Min EPS beat(2)-4.46%
Max EPS beat(2)0.99%
EPS beat(4)2
Avg EPS beat(4)3.59%
Min EPS beat(4)-21.52%
Max EPS beat(4)39.35%
EPS beat(8)5
Avg EPS beat(8)18.58%
EPS beat(12)6
Avg EPS beat(12)10.35%
EPS beat(16)8
Avg EPS beat(16)65.99%
Revenue beat(2)1
Avg Revenue beat(2)3.28%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)6.93%
Revenue beat(4)2
Avg Revenue beat(4)13.03%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)46.19%
Revenue beat(8)5
Avg Revenue beat(8)25.66%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.19%
PT rev (3m)8.36%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-1%
EPS NY rev (1m)1.09%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)0.78%
Revenue NQ rev (3m)-1.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 7.04
Fwd PE 6.9
P/S 4.53
P/FCF 8.62
P/OCF 8.54
P/B 2
P/tB N/A
EV/EBITDA 8.34
EPS(TTM)2.25
EY14.2%
EPS(NY)2.29
Fwd EY14.48%
FCF(TTM)1.84
FCFY11.6%
OCF(TTM)1.86
OCFY11.71%
SpS3.5
BVpS7.93
TBVpS-5.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.04
Profitability
Industry RankSector Rank
ROA -5.75%
ROE -11.95%
ROCE 6.33%
ROIC 4.55%
ROICexc 4.76%
ROICexgc 98.84%
OM 27.25%
PM (TTM) N/A
GM N/A
FCFM 52.55%
ROA(3y)4.16%
ROA(5y)N/A
ROE(3y)6.27%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)2.05%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.74%
ROCE(5y)N/A
ROICexgc growth 3Y44.9%
ROICexgc growth 5YN/A
ROICexc growth 3Y-7.25%
ROICexc growth 5YN/A
OM growth 3Y-6.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 4.45
Debt/EBITDA 2.53
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 66.17%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 1.37
F-Score4
WACC8.27%
ROIC/WACC0.55
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.41%
EPS 3Y5.09%
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y-4.68%
EPS Next 2Y2.83%
EPS Next 3Y9.29%
EPS Next 5Y16.93%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y32.25%
Revenue growth 5YN/A
Sales Q2Q%7%
Revenue Next Year11.36%
Revenue Next 2Y6.43%
Revenue Next 3Y6.13%
Revenue Next 5Y14.54%
EBIT growth 1Y343.32%
EBIT growth 3Y24.15%
EBIT growth 5YN/A
EBIT Next Year107.34%
EBIT Next 3Y27.94%
EBIT Next 5Y28.13%
FCF growth 1Y103.46%
FCF growth 3Y19.16%
FCF growth 5YN/A
OCF growth 1Y103.46%
OCF growth 3Y19.16%
OCF growth 5YN/A

DRI HEALTHCARE TRUST / DHT-UN.CA FAQ

What is the ChartMill fundamental rating of DRI HEALTHCARE TRUST (DHT-UN.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to DHT-UN.CA.


What is the valuation status of DRI HEALTHCARE TRUST (DHT-UN.CA) stock?

ChartMill assigns a valuation rating of 7 / 10 to DRI HEALTHCARE TRUST (DHT-UN.CA). This can be considered as Undervalued.


How profitable is DRI HEALTHCARE TRUST (DHT-UN.CA) stock?

DRI HEALTHCARE TRUST (DHT-UN.CA) has a profitability rating of 3 / 10.


What is the valuation of DRI HEALTHCARE TRUST based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DRI HEALTHCARE TRUST (DHT-UN.CA) is 7.04 and the Price/Book (PB) ratio is 2.